Triptolide: progress on research in pharmacodynamics and toxicology

Area of Science:

• Pharmacology
• Toxicology
• Traditional Chinese Medicine

Background:

• Tripterygium wilfordii (Huangteng) is a traditional Chinese medicine containing Triptolide (TP).
• TP has demonstrated diverse pharmacological activities, including anti-rheumatism, anti-inflammatory, anti-tumor, and neuroprotective properties.
• Despite its therapeutic potential, multi-organ toxicity limits the widespread clinical application of TP.

Purpose of the Study:

• To review recent advancements in the pharmacodynamics, pharmacokinetics, pharmacy, and toxicology of Triptolide (TP).
• To focus on novel mechanisms for reducing TP toxicity.
• To provide insights for future research on traditional Chinese medicine.

Main Methods:

• Literature search of online academic databases (PubMed, Google Scholar, CNKI, SciFinder, Web of Science).
• Inclusion of studies published primarily within the last five years.
• Synthesis of recent developments in TP research.

Main Results:

• TP exhibits significant anti-tumor, anti-inflammatory, and neuroprotective effects.
• It has been historically used for conditions like rheumatoid arthritis, nephritic syndrome, and lupus.
• Current understanding highlights breakthroughs in TP's pharmacological efficacy, yet toxicity remains a significant barrier.

Conclusions:

• Triptolide (TP) shows promise as an anti-tumor agent, necessitating further investigation into anti-cancer targets and clinical indications.
• Determining safe dosage ranges, clarifying toxicity mechanisms, and establishing early warning systems are crucial for optimizing TP's clinical use.
• Continued research into TP's efficacy and toxicity is expected to lead to a safer and more effective multi-use drug.